| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.600 | strong | 0.938 | 1 | 0 | 2001 | 2019 | ||||||||
|
fibroblast growth factor 2 | 0.383 | 0.923 | 1.8E-02 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1993 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.893 | 1 | 0 | 2007 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2018 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
disease | 0.370 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.350 | None | 1.000 | 1 | 0 | 2005 | 2020 | ||||||||
|
midkine | 0.494 | 0.808 | 0.23 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
neurotrophic receptor tyrosine kinase 1 | 0.422 | 0.808 | 2.0E-06 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
chloride voltage-gated channel 3 | 0.621 | 0.615 | 1.00 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2003 | 2018 | ||||||||
|
ATPase Na+/K+ transporting subunit beta 2 | 0.705 | 0.308 | 7.4E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2003 | 2006 | ||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2003 | 2013 | ||||||||
|
chloride voltage-gated channel 2 | 0.626 | 0.462 | 5.5E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
deleted in malignant brain tumors 1 | 0.533 | 0.654 | 4.5E-63 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.300 | None | 0.950 | 1 | 0 | 1994 | 2019 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.250 | None | 0.833 | 1 | 0 | 2000 | 2019 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2005 | ||||||||
|
MDM4 regulator of p53 | 0.461 | 0.808 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 2019 | ||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase 8 | 0.397 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1999 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.955 | 1 | 0 | 1996 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
disease | 0.100 | None | 0.923 | 1 | 0 | 2005 | 2015 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.985 | 1 | 0 | 2004 | 2020 | ||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
disease | 0.100 | None | 0.944 | 1 | 0 | 2002 | 2019 |